PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Actinium Pharmaceuticals, Inc. (ATNM)
1.780.01 (-0.56%)
1.75 - 1.81
1.03 - 2.41
122.5K / 296.7K (Avg.)
-1.36 | -1.31
Analyze DCF forecasts for the company and compare them with competitors.
No Data
No DCF data available for this metric in the selected year.
-50.53%
No peer data available for comparison.
No Data
No DCF data available for this metric in the selected year.
-20.00%
No peer data available for comparison.
No Data
No DCF data available for this metric in the selected year.
-20.00%
No peer data available for comparison.
No Data
No DCF data available for this metric in the selected year.
No Data
No DCF data available for this metric in the selected year.
100.00%
No peer data available for comparison.
No Data
No DCF data available for this metric in the selected year.
40.00%
No peer data available for comparison.
No Data
No DCF data available for this metric in the selected year.
40.00%
No peer data available for comparison.
No Data
No DCF data available for this metric in the selected year.
100.00%
No peer data available for comparison.
No Data
No DCF data available for this metric in the selected year.
-29.43%
No peer data available for comparison.
4.99%
No peer data available for comparison.
5.02%
No peer data available for comparison.
4.08%
No peer data available for comparison.
-0.23
No peer data available for comparison.
30.07M
No peer data available for comparison.
1.57M
No peer data available for comparison.
49.31M
No peer data available for comparison.
50.89M
No peer data available for comparison.
3.09%
No peer data available for comparison.
96.91%
No peer data available for comparison.
No Data
No DCF data available for this metric in the selected year.
No Data
No DCF data available for this metric in the selected year.
2.00%
No peer data available for comparison.
No Data
No DCF data available for this metric in the selected year.
No Data
No DCF data available for this metric in the selected year.
-71.33M
No peer data available for comparison.
71.33M
No peer data available for comparison.
2.37
No peer data available for comparison.
Analyze analyst forecasts for the company and compare them with competitors.
180.25K
Worse than AFMD's estimated revenue of 10.53M.
-36.05K
Better than AFMD's estimated ebitda of -10.53M.
-2.06
Better than AFMD's estimated eps of -7.37.
-62.22M
Better than AFMD's estimated net income of -110.16M.
-36.05K
Better than AFMD's estimated ebit of -10.53M.
6.68M
Better than AFMD's estimated sg&a expense of 11.21M.
View analysts' price targets and recommendations, and compare them with competitors.
$11.07
Analysts expect the stock price to increase by 521.91%.
Buy
Positive consensus among analysts.